Page 2 - Viz Platform News Today

New partnership incorporates latest perfusion technology into the Viz.ai platform Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership

Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment - read this article along with other careers information, tips and advice on BioSpace

Viz.ai announced today that it received FDA 510(k) clearance for its automated RV/LV ratio algorithm as part of the Viz PE solution.

Viz.ai announced today that it received FDA 510(k) clearance for its Viz Subdural (SDH) artificial intelligence (AI) algorithm.

The company’s platform has raised $100 million in its latest round, and shows no signs of stopping.

The company has pioneered the use of AI algorithms and machine learning to increase the speed of diagnosis and care for a variety of diseases in hospitals and health systems.

Artificial intelligence-based disease detection technology company Viz.ai announced that it raised $100 million in a Series D financing round.

Viz.ai, a San Francisco-based AI-powered disease detection and care coordination platform raises $1000M in Series D funding

WFP Angola Country Brief, February 2021 Format In Numbers 194 mt food assistance distributed in January to 6,740 DRC refugees in the province of Luanda Norte 228 mt of supplementary foods procured for the COVID-19 acute malnutrition response in Luanda Province US$ 3.21 million six-month (March–August 2021) net funding requirements 4.8 million people with insufficient food consumption (mVAM data from March 2021) Operational Updates Refugee Response • Since March 2020, WFP has reduced the fre...